首页/数据集/Additional file 2 of Minimal residual disease profiling predicts pathological complete response in esophageal squamous cell carcinoma

Additional file 2 of Minimal residual disease profiling predicts pathological complete response in esophageal squamous cell carcinoma

NIAID Data Ecosystem2026-05-02 收录

癌症治疗反应预测

微小残留病灶分析

数据链接：

https://figshare.com/articles/dataset/Additional_file_2_of_Minimal_residual_disease_profiling_predicts_pathological_complete_response_in_esophageal_squamous_cell_carcinoma/25801098 数据链接链接失效反馈

官方服务：

资源简介：

Supplementary Material 2

应用场景：

创建时间：

2024-05-10

癌症治疗反应预测

肿瘤体积测量

Objectives: Early assessment of hepatocellular carcinoma (HCC) response during sorafenib (SO) treatment is challenging, since tumor necrosis, extension and radiological appearance can be inhomogeneous

NIAID Data Ecosystem80

DNA methylation markers panel can improve prediction of response to neoadjuvant chemotherapy in luminal B breast cancer

癌症治疗反应预测

甲基化DNA生物标志物

Despite the advantages of neoadjuvant chemotherapy (NACT), associated toxicity is a serious complication that renders monitoring of the patients response to NACT highly important. Thus, prediction of

NIAID Data Ecosystem40

Supplementary Material for: Prediction of Therapeutic Response Using Contrast-Enhanced Ultrasound in Japanese Patients Treated with Atezolizumab and Bevacizumab for Unresectable Hepatocellular Carcinoma

癌症治疗反应预测

对比增强超声

Introduction: Atezolizumab and bevacizumab (AB) therapy was the first-line treatment for unresectable hepatocellular carcinoma (u-HCC). However, the predictive marker of therapeutic response that can

NIAID Data Ecosystem20

MiRNA expression arrays from esophageal squamous cell carcinomas with different neoadjuvant chemoradiotherapy response. Homo sapiens

miRNA生物标志物

癌症治疗反应预测

Preoperative chemoradiotherapy (CRT) followed by surgery has been proved to improve esophageal squamous cell carcinoma (ESCC) patients’ survival in comparison with surgery alone. However, the outcomes

NIAID Data Ecosystem50

Supplementary File 3 from Active Estrogen Receptor-alpha Signaling in Ovarian Cancer Models and Clinical Specimens

癌症治疗反应预测

肿瘤标志物CA-125

Supplementary File 3 contains the available pre- and post-treatment CA-125 data for our patient cohort.

NIAID Data Ecosystem30